Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

The fecal immunochemical test (FIT) is commonly used for colorectal cancer screening and positive test results require follow-up colonoscopy. However, follow-up intervals vary, which may result in neoplastic progression. To evaluate time to colonoscopy after a positive FIT result and its association...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	JAMA : the journal of the American Medical Association Ročník 317; číslo 16; s. 1631
Hlavní autoři:	Corley, Douglas A, Jensen, Christopher D, Quinn, Virginia P, Doubeni, Chyke A, Zauber, Ann G, Lee, Jeffrey K, Schottinger, Joanne E, Marks, Amy R, Zhao, Wei K, Ghai, Nirupa R, Lee, Alexander T, Contreras, Richard, Quesenberry, Charles P, Fireman, Bruce H, Levin, Theodore R
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 25.04.2017
Témata:	Aged Cohort Studies Colonoscopy Colorectal Neoplasms - diagnosis Colorectal Neoplasms - pathology Disease Progression Early Detection of Cancer Female Humans Male Middle Aged Neoplasm Staging Occult Blood Odds Ratio Retrospective Studies Risk Factors Time Factors
ISSN:	1538-3598, 1538-3598
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	The fecal immunochemical test (FIT) is commonly used for colorectal cancer screening and positive test results require follow-up colonoscopy. However, follow-up intervals vary, which may result in neoplastic progression. To evaluate time to colonoscopy after a positive FIT result and its association with risk of colorectal cancer and advanced-stage disease at diagnosis. Retrospective cohort study (January 1, 2010-December 31, 2014) within Kaiser Permanente Northern and Southern California. Participants were 70 124 patients aged 50 through 70 years eligible for colorectal cancer screening with a positive FIT result who had a follow-up colonoscopy. Time (days) to colonoscopy after a positive FIT result. Risk of any colorectal cancer and advanced-stage disease (defined as stage III and IV cancer). Odds ratios (ORs) and 95% CIs were adjusted for patient demographics and baseline risk factors. Of the 70 124 patients with positive FIT results (median age, 61 years [IQR, 55-67 years]; men, 52.7%), there were 2191 cases of any colorectal cancer and 601 cases of advanced-stage disease diagnosed. Compared with colonoscopy follow-up within 8 to 30 days (n = 27 176), there were no significant differences between follow-up at 2 months (n = 24 644), 3 months (n = 8666), 4 to 6 months (n = 5251), or 7 to 9 months (n = 1335) for risk of any colorectal cancer (cases per 1000 patients: 8-30 days, 30; 2 months, 28; 3 months, 31; 4-6 months, 31; and 7-9 months, 43) or advanced-stage disease (cases per 1000 patients: 8-30 days, 8; 2 months, 7; 3 months, 7; 4-6 months, 9; and 7-9 months, 13). Risks were significantly higher for examinations at 10 to 12 months (n = 748) for any colorectal cancer (OR, 1.48 [95% CI, 1.05-2.08]; 49 cases per 1000 patients) and advanced-stage disease (OR, 1.97 [95% CI, 1.14-3.42]; 19 cases per 1000 patients) and more than 12 months (n = 747) for any colorectal cancer (OR, 2.25 [95% CI, 1.89-2.68]; 76 cases per 1000 patients) and advanced-stage disease (OR, 3.22 [95% CI, 2.44-4.25]; 31 cases per 1000 patients). Among patients with a positive fecal immunochemical test result, compared with follow-up colonoscopy at 8 to 30 days, follow-up after 10 months was associated with a higher risk of colorectal cancer and more advanced-stage disease at the time of diagnosis. Further research is needed to assess whether this relationship is causal.
AbstractList	The fecal immunochemical test (FIT) is commonly used for colorectal cancer screening and positive test results require follow-up colonoscopy. However, follow-up intervals vary, which may result in neoplastic progression.IMPORTANCEThe fecal immunochemical test (FIT) is commonly used for colorectal cancer screening and positive test results require follow-up colonoscopy. However, follow-up intervals vary, which may result in neoplastic progression.To evaluate time to colonoscopy after a positive FIT result and its association with risk of colorectal cancer and advanced-stage disease at diagnosis.OBJECTIVETo evaluate time to colonoscopy after a positive FIT result and its association with risk of colorectal cancer and advanced-stage disease at diagnosis.Retrospective cohort study (January 1, 2010-December 31, 2014) within Kaiser Permanente Northern and Southern California. Participants were 70 124 patients aged 50 through 70 years eligible for colorectal cancer screening with a positive FIT result who had a follow-up colonoscopy.DESIGN, SETTING, AND PARTICIPANTSRetrospective cohort study (January 1, 2010-December 31, 2014) within Kaiser Permanente Northern and Southern California. Participants were 70 124 patients aged 50 through 70 years eligible for colorectal cancer screening with a positive FIT result who had a follow-up colonoscopy.Time (days) to colonoscopy after a positive FIT result.EXPOSURESTime (days) to colonoscopy after a positive FIT result.Risk of any colorectal cancer and advanced-stage disease (defined as stage III and IV cancer). Odds ratios (ORs) and 95% CIs were adjusted for patient demographics and baseline risk factors.MAIN OUTCOMES AND MEASURESRisk of any colorectal cancer and advanced-stage disease (defined as stage III and IV cancer). Odds ratios (ORs) and 95% CIs were adjusted for patient demographics and baseline risk factors.Of the 70 124 patients with positive FIT results (median age, 61 years [IQR, 55-67 years]; men, 52.7%), there were 2191 cases of any colorectal cancer and 601 cases of advanced-stage disease diagnosed. Compared with colonoscopy follow-up within 8 to 30 days (n = 27 176), there were no significant differences between follow-up at 2 months (n = 24 644), 3 months (n = 8666), 4 to 6 months (n = 5251), or 7 to 9 months (n = 1335) for risk of any colorectal cancer (cases per 1000 patients: 8-30 days, 30; 2 months, 28; 3 months, 31; 4-6 months, 31; and 7-9 months, 43) or advanced-stage disease (cases per 1000 patients: 8-30 days, 8; 2 months, 7; 3 months, 7; 4-6 months, 9; and 7-9 months, 13). Risks were significantly higher for examinations at 10 to 12 months (n = 748) for any colorectal cancer (OR, 1.48 [95% CI, 1.05-2.08]; 49 cases per 1000 patients) and advanced-stage disease (OR, 1.97 [95% CI, 1.14-3.42]; 19 cases per 1000 patients) and more than 12 months (n = 747) for any colorectal cancer (OR, 2.25 [95% CI, 1.89-2.68]; 76 cases per 1000 patients) and advanced-stage disease (OR, 3.22 [95% CI, 2.44-4.25]; 31 cases per 1000 patients).RESULTSOf the 70 124 patients with positive FIT results (median age, 61 years [IQR, 55-67 years]; men, 52.7%), there were 2191 cases of any colorectal cancer and 601 cases of advanced-stage disease diagnosed. Compared with colonoscopy follow-up within 8 to 30 days (n = 27 176), there were no significant differences between follow-up at 2 months (n = 24 644), 3 months (n = 8666), 4 to 6 months (n = 5251), or 7 to 9 months (n = 1335) for risk of any colorectal cancer (cases per 1000 patients: 8-30 days, 30; 2 months, 28; 3 months, 31; 4-6 months, 31; and 7-9 months, 43) or advanced-stage disease (cases per 1000 patients: 8-30 days, 8; 2 months, 7; 3 months, 7; 4-6 months, 9; and 7-9 months, 13). Risks were significantly higher for examinations at 10 to 12 months (n = 748) for any colorectal cancer (OR, 1.48 [95% CI, 1.05-2.08]; 49 cases per 1000 patients) and advanced-stage disease (OR, 1.97 [95% CI, 1.14-3.42]; 19 cases per 1000 patients) and more than 12 months (n = 747) for any colorectal cancer (OR, 2.25 [95% CI, 1.89-2.68]; 76 cases per 1000 patients) and advanced-stage disease (OR, 3.22 [95% CI, 2.44-4.25]; 31 cases per 1000 patients).Among patients with a positive fecal immunochemical test result, compared with follow-up colonoscopy at 8 to 30 days, follow-up after 10 months was associated with a higher risk of colorectal cancer and more advanced-stage disease at the time of diagnosis. Further research is needed to assess whether this relationship is causal.CONCLUSIONS AND RELEVANCEAmong patients with a positive fecal immunochemical test result, compared with follow-up colonoscopy at 8 to 30 days, follow-up after 10 months was associated with a higher risk of colorectal cancer and more advanced-stage disease at the time of diagnosis. Further research is needed to assess whether this relationship is causal. The fecal immunochemical test (FIT) is commonly used for colorectal cancer screening and positive test results require follow-up colonoscopy. However, follow-up intervals vary, which may result in neoplastic progression. To evaluate time to colonoscopy after a positive FIT result and its association with risk of colorectal cancer and advanced-stage disease at diagnosis. Retrospective cohort study (January 1, 2010-December 31, 2014) within Kaiser Permanente Northern and Southern California. Participants were 70 124 patients aged 50 through 70 years eligible for colorectal cancer screening with a positive FIT result who had a follow-up colonoscopy. Time (days) to colonoscopy after a positive FIT result. Risk of any colorectal cancer and advanced-stage disease (defined as stage III and IV cancer). Odds ratios (ORs) and 95% CIs were adjusted for patient demographics and baseline risk factors. Of the 70 124 patients with positive FIT results (median age, 61 years [IQR, 55-67 years]; men, 52.7%), there were 2191 cases of any colorectal cancer and 601 cases of advanced-stage disease diagnosed. Compared with colonoscopy follow-up within 8 to 30 days (n = 27 176), there were no significant differences between follow-up at 2 months (n = 24 644), 3 months (n = 8666), 4 to 6 months (n = 5251), or 7 to 9 months (n = 1335) for risk of any colorectal cancer (cases per 1000 patients: 8-30 days, 30; 2 months, 28; 3 months, 31; 4-6 months, 31; and 7-9 months, 43) or advanced-stage disease (cases per 1000 patients: 8-30 days, 8; 2 months, 7; 3 months, 7; 4-6 months, 9; and 7-9 months, 13). Risks were significantly higher for examinations at 10 to 12 months (n = 748) for any colorectal cancer (OR, 1.48 [95% CI, 1.05-2.08]; 49 cases per 1000 patients) and advanced-stage disease (OR, 1.97 [95% CI, 1.14-3.42]; 19 cases per 1000 patients) and more than 12 months (n = 747) for any colorectal cancer (OR, 2.25 [95% CI, 1.89-2.68]; 76 cases per 1000 patients) and advanced-stage disease (OR, 3.22 [95% CI, 2.44-4.25]; 31 cases per 1000 patients). Among patients with a positive fecal immunochemical test result, compared with follow-up colonoscopy at 8 to 30 days, follow-up after 10 months was associated with a higher risk of colorectal cancer and more advanced-stage disease at the time of diagnosis. Further research is needed to assess whether this relationship is causal.
Author	Jensen, Christopher D Ghai, Nirupa R Zhao, Wei K Levin, Theodore R Marks, Amy R Fireman, Bruce H Doubeni, Chyke A Quesenberry, Charles P Lee, Jeffrey K Zauber, Ann G Lee, Alexander T Corley, Douglas A Contreras, Richard Schottinger, Joanne E Quinn, Virginia P
Author_xml	– sequence: 1 givenname: Douglas A surname: Corley fullname: Corley, Douglas A organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 2 givenname: Christopher D surname: Jensen fullname: Jensen, Christopher D organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 3 givenname: Virginia P surname: Quinn fullname: Quinn, Virginia P organization: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena – sequence: 4 givenname: Chyke A surname: Doubeni fullname: Doubeni, Chyke A organization: Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia – sequence: 5 givenname: Ann G surname: Zauber fullname: Zauber, Ann G organization: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York – sequence: 6 givenname: Jeffrey K surname: Lee fullname: Lee, Jeffrey K organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 7 givenname: Joanne E surname: Schottinger fullname: Schottinger, Joanne E organization: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena – sequence: 8 givenname: Amy R surname: Marks fullname: Marks, Amy R organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 9 givenname: Wei K surname: Zhao fullname: Zhao, Wei K organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 10 givenname: Nirupa R surname: Ghai fullname: Ghai, Nirupa R organization: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena – sequence: 11 givenname: Alexander T surname: Lee fullname: Lee, Alexander T organization: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena – sequence: 12 givenname: Richard surname: Contreras fullname: Contreras, Richard organization: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena – sequence: 13 givenname: Charles P surname: Quesenberry fullname: Quesenberry, Charles P organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 14 givenname: Bruce H surname: Fireman fullname: Fireman, Bruce H organization: Division of Research, Kaiser Permanente Northern California, Oakland – sequence: 15 givenname: Theodore R surname: Levin fullname: Levin, Theodore R organization: Division of Research, Kaiser Permanente Northern California, Oakland
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28444278$$D View this record in MEDLINE/PubMed
BookMark	eNpNUE1PwzAMjdAQ-4ArR5Qjl47mo216HIMBEhJojHPlde6U0SajSUH7A_xuMhgSPtjP9nu25SHpGWuQkHMWj1kcs6sNNDDmMcvGIhXyiAxYIlQkklz1_uE-GTq3iYMxkZ2QPldSSp6pAfmaOGdLDV5bQ6_RfyIautANUm_p1NbWWFfa7Y5OKo8tBfpsnfb6A-kMS6jpAp2nc3Rd7SmYFZ1r90Zt9SNtsfSBMgVT7qWhe4AvHtZIwdMbDeuwQLtTclxB7fDsEEfkdXa7mN5Hj093D9PJYwRSKh9lnOXIsyRmyDARqcpDLnkOcZrzEgSmYonB7wtlJrgEoSBjWHFQ4Q8VH5HL37nb1r534fai0a7EugaDtnMFUzkXQqa5CNSLA7VbNrgqtq1uoN0Vf7_j36SCcmA
CitedBy_id	crossref_primary_10_1016_j_jfma_2017_09_010 crossref_primary_10_3390_cancers14225557 crossref_primary_10_1172_JCI143776 crossref_primary_10_1016_j_ypmed_2021_106622 crossref_primary_10_1016_j_jeph_2024_202555 crossref_primary_10_1080_03007995_2025_2529984 crossref_primary_10_1155_2018_9450754 crossref_primary_10_1053_j_gastro_2020_07_033 crossref_primary_10_3322_caac_21615 crossref_primary_10_1186_s12885_022_09292_y crossref_primary_10_1111_jgh_15381 crossref_primary_10_1177_1756284820965070 crossref_primary_10_1038_s41598_020_59032_0 crossref_primary_10_14309_ctg_0000000000000010 crossref_primary_10_1053_j_gastro_2021_02_047 crossref_primary_10_1007_s00464_023_10548_2 crossref_primary_10_1111_ajr_12569 crossref_primary_10_1007_s10552_024_01898_w crossref_primary_10_14309_ajg_0000000000001122 crossref_primary_10_1016_j_cgh_2018_01_004 crossref_primary_10_3390_cancers12092412 crossref_primary_10_1053_j_gastro_2018_09_040 crossref_primary_10_1177_09691413241239023 crossref_primary_10_1136_gutjnl_2019_318370 crossref_primary_10_1177_2050640620949714 crossref_primary_10_14309_ctg_0000000000000460 crossref_primary_10_1016_j_gastrohep_2020_05_004 crossref_primary_10_1007_s12029_024_01118_3 crossref_primary_10_1016_j_mcna_2023_06_002 crossref_primary_10_1177_17562848211028117 crossref_primary_10_1186_s12876_024_03242_7 crossref_primary_10_1097_PTS_0000000000000718 crossref_primary_10_1002_ijc_32497 crossref_primary_10_1080_14737167_2025_2458044 crossref_primary_10_1186_s12876_020_01262_7 crossref_primary_10_1053_j_gastro_2020_07_011 crossref_primary_10_1177_15404153231212659 crossref_primary_10_14309_ctg_0000000000000113 crossref_primary_10_1038_s41395_018_0386_z crossref_primary_10_1093_jnci_djae140 crossref_primary_10_1016_j_canep_2024_102629 crossref_primary_10_1016_j_cgh_2020_09_008 crossref_primary_10_1177_0969141321997482 crossref_primary_10_1111_hex_14126 crossref_primary_10_1002_cam4_2745 crossref_primary_10_1016_j_cgh_2024_09_036 crossref_primary_10_1093_milmed_usaa577 crossref_primary_10_1016_j_cgh_2020_02_043 crossref_primary_10_1007_s11606_020_05776_4 crossref_primary_10_1016_j_cgh_2020_06_053 crossref_primary_10_1158_1940_6207_CAPR_23_0498 crossref_primary_10_14309_ajg_0000000000003631 crossref_primary_10_1177_10732748251351744 crossref_primary_10_1158_1940_6207_CAPR_21_0075 crossref_primary_10_3390_ijerph19137569 crossref_primary_10_3390_gidisord4030013 crossref_primary_10_1007_s11739_020_02565_z crossref_primary_10_1212_WNL_0000000000200163 crossref_primary_10_3390_cancers12092610 crossref_primary_10_1007_s11606_024_08764_0 crossref_primary_10_31146_1682_8658_ecg_205_9_183_189 crossref_primary_10_1111_ans_14305 crossref_primary_10_14309_ajg_0000000000002754 crossref_primary_10_1016_j_dld_2021_02_007 crossref_primary_10_1158_1940_6207_CAPR_18_0182 crossref_primary_10_1016_j_gie_2024_11_016 crossref_primary_10_1007_s11606_021_07193_7 crossref_primary_10_1016_j_cgh_2022_11_032 crossref_primary_10_3390_ijerph192215249 crossref_primary_10_1053_j_gastro_2020_04_049 crossref_primary_10_1136_gutjnl_2022_327377 crossref_primary_10_1515_dx_2019_0104 crossref_primary_10_1016_j_dld_2018_12_008 crossref_primary_10_1093_ije_dyy182 crossref_primary_10_14309_ctg_0000000000000307 crossref_primary_10_1002_ags3_12616 crossref_primary_10_1007_s11606_020_05728_y crossref_primary_10_1111_den_14772 crossref_primary_10_5888_pcd16_180452 crossref_primary_10_1007_s00384_020_03635_6 crossref_primary_10_1136_gutjnl_2018_316762 crossref_primary_10_1016_j_cgh_2018_10_041 crossref_primary_10_1093_jncics_pkz024 crossref_primary_10_1111_jrh_12793 crossref_primary_10_1007_s10620_020_06228_z crossref_primary_10_1136_bmjph_2024_001734 crossref_primary_10_1186_s12876_021_01923_1 crossref_primary_10_1177_0969141320919152 crossref_primary_10_1001_jamanetworkopen_2024_2693 crossref_primary_10_1001_jamanetworkopen_2021_20159 crossref_primary_10_1038_s41571_025_01037_7 crossref_primary_10_1007_s40615_020_00721_x crossref_primary_10_1007_s10620_021_07313_7 crossref_primary_10_1016_j_cct_2024_107639 crossref_primary_10_1016_j_mcna_2018_08_010 crossref_primary_10_1038_s41395_018_0381_4 crossref_primary_10_1007_s00464_021_08588_7 crossref_primary_10_1016_j_cct_2023_107353 crossref_primary_10_1111_codi_16232 crossref_primary_10_1146_annurev_med_051619_035840 crossref_primary_10_1177_21501319251348099 crossref_primary_10_1007_s00384_020_03816_3 crossref_primary_10_1177_15330338241263616 crossref_primary_10_1016_j_cgh_2022_12_006 crossref_primary_10_1016_j_gastre_2020_05_001 crossref_primary_10_1002_cncr_34157 crossref_primary_10_3322_caac_21457 crossref_primary_10_1080_14737140_2017_1392243 crossref_primary_10_3748_wjg_v26_i48_7652 crossref_primary_10_3322_caac_21452 crossref_primary_10_1016_j_canep_2020_101839 crossref_primary_10_1007_s15006_017_9611_8 crossref_primary_10_1016_j_ejso_2018_06_013 crossref_primary_10_3748_wjg_v29_i9_1492 crossref_primary_10_1055_a_1159_0644 crossref_primary_10_1080_08998280_2019_1647702 crossref_primary_10_1016_j_omtn_2019_08_009 crossref_primary_10_1001_jamanetworkopen_2022_15490 crossref_primary_10_1053_j_gastro_2024_08_002 crossref_primary_10_1007_s10903_025_01685_y crossref_primary_10_7326_ANNALS_24_01885 crossref_primary_10_3322_caac_21446 crossref_primary_10_1016_j_gastha_2025_100706 crossref_primary_10_1007_s11606_019_05117_0 crossref_primary_10_14309_ajg_0000000000000790 crossref_primary_10_14309_ajg_0000000000001742 crossref_primary_10_1002_cam4_4907 crossref_primary_10_1016_j_respe_2023_102124 crossref_primary_10_1038_s41416_020_0754_5 crossref_primary_10_1016_j_giec_2021_05_012 crossref_primary_10_1016_j_gie_2020_03_3863 crossref_primary_10_1007_s10620_021_06866_x crossref_primary_10_1016_j_cgh_2024_07_001 crossref_primary_10_5604_01_3001_0015_7299 crossref_primary_10_1053_j_gastro_2020_05_047 crossref_primary_10_1111_ecc_13100 crossref_primary_10_1371_journal_pone_0267112 crossref_primary_10_1016_j_gie_2019_11_035 crossref_primary_10_1002_cam4_2735 crossref_primary_10_1111_imj_15446 crossref_primary_10_2147_CMAR_S255895 crossref_primary_10_14309_ajg_0000000000003480 crossref_primary_10_1080_03007995_2022_2116172 crossref_primary_10_1007_s00384_021_03956_0 crossref_primary_10_1055_a_1231_5123 crossref_primary_10_1001_jamanetworkopen_2024_2652 crossref_primary_10_1053_j_gastro_2020_09_018 crossref_primary_10_1016_j_dld_2020_06_023 crossref_primary_10_1186_s43058_021_00194_x crossref_primary_10_1186_s13045_020_00984_1 crossref_primary_10_1111_jgh_15762 crossref_primary_10_1016_j_cgh_2020_09_036 crossref_primary_10_1002_hsr2_71011 crossref_primary_10_1002_cam4_5850 crossref_primary_10_1016_j_jss_2024_05_036 crossref_primary_10_1136_bmjoq_2018_000400 crossref_primary_10_1371_journal_pone_0258130 crossref_primary_10_1016_j_gie_2020_06_042 crossref_primary_10_1053_j_gastro_2021_01_219 crossref_primary_10_1177_2050640619828185 crossref_primary_10_1136_bmj_n1855 crossref_primary_10_1007_s10654_018_0471_z crossref_primary_10_14309_ctg_0000000000000730 crossref_primary_10_1177_09691413211056777 crossref_primary_10_1016_j_cct_2019_105920 crossref_primary_10_1016_j_cgh_2022_07_031 crossref_primary_10_1093_jcag_gwac005 crossref_primary_10_3390_gidisord6010004 crossref_primary_10_1007_s11606_022_07657_4 crossref_primary_10_3389_fgene_2025_1514205 crossref_primary_10_1002_jgh3_12525 crossref_primary_10_1136_gutjnl_2020_322192 crossref_primary_10_1177_2150132720958525 crossref_primary_10_1016_j_gie_2024_07_008 crossref_primary_10_14309_ajg_0000000000000970 crossref_primary_10_1016_j_ypmed_2021_106643 crossref_primary_10_1016_j_gie_2021_02_013 crossref_primary_10_1016_j_cgh_2018_05_022 crossref_primary_10_1186_s12885_018_4140_0 crossref_primary_10_1001_jamanetworkopen_2022_51384 crossref_primary_10_1016_j_cgh_2019_02_011 crossref_primary_10_1016_j_tige_2023_02_003 crossref_primary_10_1016_j_giec_2020_02_002 crossref_primary_10_1016_j_giec_2020_02_003 crossref_primary_10_1053_j_gastro_2020_03_072 crossref_primary_10_1055_a_1243_1372 crossref_primary_10_1016_j_cdtm_2018_08_004 crossref_primary_10_7326_M24_0743 crossref_primary_10_1177_0969141320904977 crossref_primary_10_1016_j_amepre_2019_01_005 crossref_primary_10_1016_j_soi_2024_100014 crossref_primary_10_1016_j_ypmed_2021_106530 crossref_primary_10_1016_j_cgh_2020_09_048 crossref_primary_10_1016_j_critrevonc_2021_103273 crossref_primary_10_1016_j_tige_2020_12_005 crossref_primary_10_3390_cancers15174410 crossref_primary_10_1007_s12029_025_01187_y crossref_primary_10_1177_0033354921999173 crossref_primary_10_1111_imj_14157 crossref_primary_10_1002_cam4_70385 crossref_primary_10_1053_j_gastro_2019_11_026 crossref_primary_10_1016_j_giec_2020_02_013 crossref_primary_10_1016_j_giec_2020_02_011 crossref_primary_10_1111_jgh_15325
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1001/jama.2017.3634
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1538-3598
ExternalDocumentID	28444278
Genre	Journal Article
GrantInformation_xml	– fundername: NCI NIH HHS grantid: U54 CA163262 – fundername: NCI NIH HHS grantid: P30 CA008748 – fundername: NCI NIH HHS grantid: K07 CA212057
GroupedDBID	--- -ET -~X .55 .XZ 0R~ 0WA 186 18M 29J 2CT 2FS 2KS 2WC 354 39C 4.4 53G 5GY 5RE 6TJ 85S AAIKC AAMNW AAQOH AAQQT AAWTL ABBLC ABCQX ABEHJ ABIVO ABOCM ABPMR ABPPZ ABRSH ABWJO ACAHW ACGFS ACNCT ACPRK ADBBV ADUKH AETEA AFCHL AFFNX AFRAH AGFXO AGHSJ AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BKOMP BRYMA C45 CGR CJ0 CS3 CUY CVF EAM EBD EBS ECM EIF EJD EMOBN EX3 F5P H13 HF~ KOO KQ8 L7B MVM N4W N9A NEJ NPM OBH OCB OGEVE OHH OMK OVD P2P PQQKQ QJJ RAJ RNS S10 SJN SV3 TEORI TN5 UHB UIG UKR UPT VVN WH7 WOW X7M XHN XSW XZL YCJ YFH YOC YPV YQT YQY YR2 YR5 YSK YYM YZZ ZCA ~H1 7X8 ADXHL ARBJA
ID	FETCH-LOGICAL-a448t-7219e27501e1e5368919e429a0692ca3e63be3e69a06c7324a38a71ef2a8359f2
IEDL.DBID	7X8
ISICitedReferencesCount	229
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000400014000013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1538-3598
IngestDate	Fri Sep 05 13:45:45 EDT 2025 Thu Apr 03 06:55:56 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	16
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-a448t-7219e27501e1e5368919e429a0692ca3e63be3e69a06c7324a38a71ef2a8359f2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/6343838
PMID	28444278
PQID	1892334693
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1892334693 pubmed_primary_28444278
PublicationCentury	2000
PublicationDate	2017-Apr-25 20170425
PublicationDateYYYYMMDD	2017-04-25
PublicationDate_xml	– month: 04 year: 2017 text: 2017-Apr-25 day: 25
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	JAMA : the journal of the American Medical Association
PublicationTitleAlternate	JAMA
PublicationYear	2017
References	28444260 - JAMA. 2017 Apr 25;317(16):1627-1628
References_xml	– reference: 28444260 - JAMA. 2017 Apr 25;317(16):1627-1628
SSID	ssj0000137
Score	2.6250167
Snippet	The fecal immunochemical test (FIT) is commonly used for colorectal cancer screening and positive test results require follow-up colonoscopy. However,...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1631
SubjectTerms	Aged Cohort Studies Colonoscopy Colorectal Neoplasms - diagnosis Colorectal Neoplasms - pathology Disease Progression Early Detection of Cancer Female Humans Male Middle Aged Neoplasm Staging Occult Blood Odds Ratio Retrospective Studies Risk Factors Time Factors
Title	Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis
URI	https://www.ncbi.nlm.nih.gov/pubmed/28444278 https://www.proquest.com/docview/1892334693
Volume	317
WOSCitedRecordID	wos000400014000013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvRvAabbJ5nqRWiwdbilTorWyTWSlKUpu04B_wdzuzSbEXQfCyJJssLDuzs9_uzH4jxBVGfuA3HG1hTJPcTaS2GJZbSezpMLQbSivDrv8UdLvhYBD1qgO3vAqrXNhEY6iTLOYz8hs7JCgiaTMnbycfFmeNYu9qlUJjVdQkQRnW6mAQLtFHGc5MM6mZqW5B2vjDOmQH19LnpMm_wUuzzLS3_9vBHbFVAUxolhqxK1Yw3RMbncqFvi--lgQCd2WUFvBFECgyaJEpTDO-qfIJTc4eDgp6JqxrjtBGkif0qUfwjPnsvQCVJvA8zt8g06YpW0_6pcWaNDVfq0eCtK8IqoD7MrJvnB-Il_ZDv_VoVckYLEU7uMKinWKETAZvo42e9MOI3mkxUw0_cmIl0ZcjpJIr4oBgmpKhCmzUjiKQF2nnUKylWYrHAlypvRHBKM_VhBfJzHkEJGI_cHVDJ5EzqovLxQgPSdnZg6FSzGb58GeM6-KoFNNwUrJyDGmddTlvyMkfWp-KTZY9e4Uc70zUNE11PBfr8bwY59MLo0VUdnudb1_Q0NM
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+Between+Time+to+Colonoscopy+After+a+Positive+Fecal+Test+Result+and+Risk+of+Colorectal+Cancer+and+Cancer+Stage+at+Diagnosis&rft.jtitle=JAMA+%3A+the+journal+of+the+American+Medical+Association&rft.au=Corley%2C+Douglas+A&rft.au=Jensen%2C+Christopher+D&rft.au=Quinn%2C+Virginia+P&rft.au=Doubeni%2C+Chyke+A&rft.date=2017-04-25&rft.eissn=1538-3598&rft.volume=317&rft.issue=16&rft.spage=1631&rft_id=info:doi/10.1001%2Fjama.2017.3634&rft_id=info%3Apmid%2F28444278&rft_id=info%3Apmid%2F28444278&rft.externalDocID=28444278
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-3598&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-3598&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-3598&client=summon